The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Wed, 12th Nov 2014 12:02

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
G4S, up 4.3%. The security company said organic revenue rose 4.2% in the first nine months of the year and it has agreed new contracts with annual revenues of over GBP870 million and total contract value of GBP1.7 billion. Contract retention for the nine months was similar to historical levels, at slightly above 90%, the company said.

Tullow Oil, up 1.5%. The oil explorer said it is reviewing its capital expenditure and costs, with overall exploration spending significantly reduced and focused primarily on East Africa where it has major basin-opening potential.
-------
FTSE 100 LOSERS
-------
Sainsbury's, down 5.4%. The supermarket operator swung to a pretax loss in the first half of the year, and outlined plans to cuts costs and capital expenditure. Pretax loss was GBP290 million for the 28 weeks to September 27 from a profit of GBP433 million in the same period a year earlier. First-half revenue fell 0.1% to GBP12.67 billion. It maintained its interim dividend, but its full-year dividend is expected to be cut.

Capita, down 5%. The outsourcing company said it has secured GBP1.63 billion of major sales so far this year, down from GBP2.9 billion in the same period last year when it had booked its largest ever contract worth GBP1.2 billion with O2.

SSE, down 2.7%. The utility reported a drop in pretax profit in the first half of the year due to warmer weather, lower electricity output and weak gas prices. For the six months ended September 30, pretax profit fell 6.2% to GBP316.6 million compared with GBP337.4 million a year earlier, mainly driven by a GBP22.1 million loss from its share of joint ventures.

Barclays, down 2%. The bank was among the five investigated by regulators over its FX dealings but remains in talks with regulators over its settlement. It has set aside GBP500 million in provisions to cover potential fines.

Burberry, down 1.2%. The luxury fashion retailer reported a 14% rise in underlying revenue of GBP1.1 billion but said it expects some pressure on full-year margin, a reflection of the strong pound, a more difficult external environment, and continued investments.

Royal Bank of Scotland, down 0.4%. The bank was one of five fined a total USD3.38 billion by UK, US and Swiss regulators for failings in its FX dealing operations. RBS was fined GBP399 million but said this is fully covered by provisions made in the third quarter.
-------
FTSE 250 WINNERS
-------
Essentra, up 2.5%. The company said it will buy the specialist packing arm of Clondalkin Group in a USD455 million deal, issuing shares to cover GBP160 million of the consideration. Clondalkin, which provides secondary packaging products for the pharmaceutical and healthcare industries, is owned by an affiliate of US private equity house Warburg Pincus and Essentra expects to complete the deal in the first quarter of 2015.

Moneysupermarket.com, up 2%. The price comparison website said it remains confident of meeting its expectations for the full year, after the "positive momentum and solid margins" seen in the third quarter continued through October. Third-quarter revenue rose by 18% year-on-year to GBP66.8 million, driven by increases in MoneySuperMarket.com, MoneySavingExpert.com, and TravelSupermarket.com, the company said
-------
FTSE 250 LOSERS
-------
SIG, down 7.5%. The building products distributor lowered its expectations for the year due to weak economic conditions in Europe, although it also raised its cost-benefit targets from the strategic initiatives it is taking.

Playtech, down 7.5%. Credit Suisse cut its rating on the stock to Underperform from Neutral and lowered its price target to 580 pence from 780p.

Diploma, down 1.6%. The company said Chairman John Rennocks is to step down from his role after the company's annual general meeting in January, appointing John Nicholas, currently a senior independent director on Diploma's board.
-------
AIM ALL-SHARE WINNERS
-------
Mountfield, up 8.1%. The company said its Connaught Access Flooring subsidiary has won a contract worth around GBP4.5 million to supply and install access flooring at a newly-built office development in the City of London. Work will start in January 2015 and is expected to be completed in the first quarter of 2016.

Solo Oil, up 7%. The company said it is awaiting formal approval from Tanzanian authorities for a deal that will see Solo buy a stake in the Kiliwani North Development license from Aminex, and the companies expect the deal to close shortly.
-------
AIM ALL-SHARE LOSERS
-------
Proteome Sciences, down 16%. The company said contract delays will mean its full-year revenue will come in below market expectations and lower than the revenue posted last year.

Quindell, down 9.6%. The company is understood to be on the brink of a formal probe by the City regulator over a share-transaction controversy which has caused its share price to plunge in the past week, the Daily Mail reported. The FCA declined to comment to Alliance News.

Physiomics, down 4%. The company posted a slightly narrowed loss in its year to end-June of GBP464,252, down from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.
-------
By Ian Edmondson; ianedmondson@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
23 Dec 2019 10:43

Physiomics Signs Further Project Agreement With CellCentric

Physiomics Signs Further Project Agreement With CellCentric

Read more
23 Dec 2019 08:33

Physiomics scores further project agreement with CellCentric

(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.

Read more
20 Dec 2019 15:26

Merck Commits To Initial Contracts With Physiomics For 2020

Merck Commits To Initial Contracts With Physiomics For 2020

Read more
20 Dec 2019 11:27

Physiomics surges amid deepened Merck collaboration

(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.

Read more
30 Sep 2019 16:06

Physiomics Achieves Record Annual Total Income And Narrows Loss

Physiomics Achieves Record Annual Total Income And Narrows Loss

Read more
30 Jul 2019 12:21

Physiomics Says Annual Performance In Line With Analyst Forecasts

(Alliance News) - Physiomics PLC on Tuesday said it traded in line with analyst expectations in its recently completed financial year.Shares in Physiomics were down 5.4% at 3.22 pence in to

Read more
8 Jul 2019 11:19

Physiomics Signs Agreement With Bicycle Therapeutics, Cancer Research

(Alliance News) - Medical prediction software developer Physiomics PLC said Monday it has signed an agreement with Nasdaq-listed biopharma firm Bicycle Therapeutics and research charity Cancer is

Read more
28 Jun 2019 10:56

Physiomics wins immune-oncology contract from Bicycle Therapeutics

(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on Friday.

Read more
14 May 2019 15:01

Physiomics Completes Innovate UK Prostate Cancer Grant Project

LONDON (Alliance News) - Physiomics PLC on Tuesday said it has completed its Innovate UK grant project and created a tool that can use routine blood tests to determine drug dosages for prostate in

Read more
20 Mar 2019 10:32

Physiomics To Meet With Potential Future Clients At AACR Conference

LONDON (Alliance News) - Physiomics PLC on Wednesday said it will use the opportunity of an upcoming conference to meet with current as well as potential future clients.Shares in the to the

Read more
21 Feb 2019 13:15

Physiomics Expects Strong Second Half As Loss Narrows, Revenue Rises

LONDON (Alliance News) - Physiomics PLC on Thursday reported a narrowed loss for the first half of its current financial year, helped by strong revenue growth.The AIM-listed company, which

Read more
21 Feb 2019 11:51

Physiomics narrows interim loss as revenue leaps

(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its revenue over the period.

Read more
17 Dec 2018 14:59

Physiomics collaboration with Merck to last another year

(Sharecast News) - Physiomics announced on Monday that, following a successful collaboration and pursuant to the master services agreement signed with US pharmaceuticals giant Merck in November last year, it had agreed with a programme of work for the next calendar year.

Read more
8 Oct 2018 09:55

Physiomics Annual Loss Halves, Revenue Doubles As New Momentum Emerges

LONDON (Alliance News) - Medical prediction software developer Physiomics PLC said Monday its full year loss halved as revenue doubled amid a "renewed" momentum at the firm.For to

Read more
9 Aug 2018 14:58

Physiomics wins small contract with European biotech client

(Sharecast News) - Cancer treatment prediction technology developer Physiomics has been awarded a contract by a new European biotech client, it announced on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.